Pesta Dominik H, Tsirigotis Dimitrios N, Befroy Douglas E, Caballero Daniel, Jurczak Michael J, Rahimi Yasmeen, Cline Gary W, Dufour Sylvie, Birkenfeld Andreas L, Rothman Douglas L, Carpenter Thomas O, Insogna Karl, Petersen Kitt Falk, Bergwitz Clemens, Shulman Gerald I
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, USA.
FASEB J. 2016 Oct;30(10):3378-3387. doi: 10.1096/fj.201600473R. Epub 2016 Jun 23.
Hypophosphatemia can lead to muscle weakness and respiratory and heart failure, but the mechanism is unknown. To address this question, we noninvasively assessed rates of muscle ATP synthesis in hypophosphatemic mice by using in vivo saturation transfer [P]-magnetic resonance spectroscopy. By using this approach, we found that basal and insulin-stimulated rates of muscle ATP synthetic flux (V) and plasma inorganic phosphate (P) were reduced by 50% in mice with diet-induced hypophosphatemia as well as in sodium-dependent P transporter solute carrier family 34, member 1 (NaPi2a)-knockout (NaPi2a) mice compared with their wild-type littermate controls. Rates of V normalized in both hypophosphatemic groups after restoring plasma P concentrations. Furthermore, V was directly related to cellular and mitochondrial P uptake in L6 and RC13 rodent myocytes and isolated muscle mitochondria. Similar findings were observed in a patient with chronic hypophosphatemia as a result of a mutation in SLC34A3 who had a 50% reduction in both serum P content and muscle V After oral P repletion and normalization of serum P levels, muscle V completely normalized in the patient. Taken together, these data support the hypothesis that decreased muscle ATP synthesis, in part, may be caused by low blood P concentrations, which may explain some aspects of muscle weakness observed in patients with hypophosphatemia.-Pesta, D. H., Tsirigotis, D. N., Befroy, D. E., Caballero, D., Jurczak, M. J., Rahimi, Y., Cline, G. W., Dufour, S., Birkenfeld, A. L., Rothman, D. L., Carpenter, T. O., Insogna, K., Petersen, K. F., Bergwitz, C., Shulman, G. I. Hypophosphatemia promotes lower rates of muscle ATP synthesis.
低磷血症可导致肌肉无力以及呼吸和心力衰竭,但其机制尚不清楚。为了解决这个问题,我们通过体内饱和转移[P]-磁共振波谱技术对低磷血症小鼠的肌肉ATP合成速率进行了无创评估。通过使用这种方法,我们发现,与野生型同窝对照小鼠相比,饮食诱导的低磷血症小鼠以及钠依赖性磷转运体溶质载体家族34成员1(NaPi2a)基因敲除(NaPi2a)小鼠的基础和胰岛素刺激的肌肉ATP合成通量(V)以及血浆无机磷(P)降低了50%。恢复血浆磷浓度后,两个低磷血症组的V率均恢复正常。此外,V与L6和RC13啮齿动物肌细胞以及分离的肌肉线粒体中的细胞和线粒体磷摄取直接相关。在一名因SLC34A3基因突变导致慢性低磷血症的患者中也观察到了类似的结果,该患者的血清磷含量和肌肉V均降低了50%。口服补充磷并使血清磷水平恢复正常后,该患者的肌肉V完全恢复正常。综上所述,这些数据支持以下假设:肌肉ATP合成减少部分可能是由低血磷浓度引起的,这可能解释了低磷血症患者出现肌肉无力的某些原因。——佩斯塔,D. H.,齐里戈蒂斯,D. N.,贝弗罗伊,D. E.,卡瓦列罗,D.,尤尔扎克,M. J.,拉希米,Y.,克莱因,G. W.,迪富尔,S.,比尔肯费尔德,A. L.,罗斯曼,D. L.,卡彭特,T. O.,因索尼亚,K.,彼得森,K. F.,伯格维茨,C.,舒尔曼,G. I. 低磷血症导致肌肉ATP合成速率降低